138 related articles for article (PubMed ID: 27215265)
1. Restless leg syndrome and its treatment.
Shubhakaran K
Saudi J Kidney Dis Transpl; 2016 May; 27(3):621. PubMed ID: 27215265
[No Abstract] [Full Text] [Related]
2. Gabapentin versus levodopa-c for the treatment of restless legs syndrome in hemodialysis patients: a randomized clinical trial.
Razazian N; Azimi H; Heidarnejadian J; Afshari D; Ghadami MR
Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):271-8. PubMed ID: 25758874
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of antipsychotic-induced restless legs syndrome with gabapentin.
Kumar V; Ambekar N; Singh A; Venkatasubramanian G
Asian J Psychiatr; 2014 Jun; 9():89-90. PubMed ID: 24813045
[No Abstract] [Full Text] [Related]
4. Gabapentin in treatment of restless legs syndrome in peritoneal dialysis patients.
Tan J; Derwa A; Sanu V; Rahman N; Woodrow G
Perit Dial Int; 2006; 26(2):276-8. PubMed ID: 16623436
[No Abstract] [Full Text] [Related]
5. Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients: an open-label study.
Micozkadioglu H; Ozdemir FN; Kut A; Sezer S; Saatci U; Haberal M
Ren Fail; 2004 Jul; 26(4):393-7. PubMed ID: 15462107
[TBL] [Abstract][Full Text] [Related]
6. Leg kicking and rubbing as a highly suggestive sign of pediatric restless legs syndrome.
Bruni O; Angriman M; Luchetti A; Ferri R
Sleep Med; 2015 Dec; 16(12):1576-7. PubMed ID: 26459674
[No Abstract] [Full Text] [Related]
7. Restless legs syndrome.
Yee B; Killick R; Wong K
Aust Fam Physician; 2009 May; 38(5):296-300. PubMed ID: 19458798
[TBL] [Abstract][Full Text] [Related]
8. Treatment of restless legs syndrome.
Spolador T; Allis JC; Pondé MP
Braz J Psychiatry; 2006 Dec; 28(4):308-15. PubMed ID: 17242812
[TBL] [Abstract][Full Text] [Related]
9. Management of restless legs syndrome in patients on dialysis.
Molnar MZ; Novak M; Mucsi I
Drugs; 2006; 66(5):607-24. PubMed ID: 16620140
[TBL] [Abstract][Full Text] [Related]
10. Restless legs syndrome: nonpharmacologic and pharmacologic treatments.
Winkelman JW; Allen RP; Tenzer P; Hening W
Geriatrics; 2007 Oct; 62(10):13-6. PubMed ID: 17922563
[TBL] [Abstract][Full Text] [Related]
11. Clinical management of restless legs syndrome in end-stage renal disease patients.
Sahli ZT; Jo J; Mousa SA; Tarazi FI
CNS Spectr; 2017 Feb; 22(1):14-21. PubMed ID: 27702420
[TBL] [Abstract][Full Text] [Related]
12. [When the legs have to keep moving at night--the restless legs syndrome].
Lanz M; Happe S
MMW Fortschr Med; 2007 May; 149 Suppl 2():42-4. PubMed ID: 17724966
[TBL] [Abstract][Full Text] [Related]
13. Restless legs syndrome as the presenting symptom of multiple myeloma.
Aricò D; Raggi A; Siragusa M; Zucconi M; Ferri R
J Clin Sleep Med; 2013 Apr; 9(4):383-5. PubMed ID: 23585755
[TBL] [Abstract][Full Text] [Related]
14. Latest guidelines and advances for treatment of restless legs syndrome.
Earley CJ
J Clin Psychiatry; 2014 Apr; 75(4):e08. PubMed ID: 24813409
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of gabapentin for uremic pruritus and restless legs syndrome in conservatively managed patients with chronic kidney disease.
Cheikh Hassan HI; Brennan F; Collett G; Josland EA; Brown MA
J Pain Symptom Manage; 2015 Apr; 49(4):782-9. PubMed ID: 25220049
[TBL] [Abstract][Full Text] [Related]
16. Restless legs syndrome: clinical experience with long-term treatment.
Clavadetscher SC; Gugger M; Bassetti CL
Sleep Med; 2004 Sep; 5(5):495-500. PubMed ID: 15341896
[TBL] [Abstract][Full Text] [Related]
17. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients.
Earley CJ; Allen RP
Sleep; 1996 Dec; 19(10):801-10. PubMed ID: 9085489
[TBL] [Abstract][Full Text] [Related]
18. [Restless legs syndrome in the elderly: an unrecognized disorder].
Biselx S; Büla C; Ghika J
Rev Med Suisse; 2008 Nov; 4(178):2382-6. PubMed ID: 19051624
[TBL] [Abstract][Full Text] [Related]
19. Restless legs syndrome.
Feigen A
JAMA; 1995 Oct; 274(15):1191-2. PubMed ID: 7563499
[No Abstract] [Full Text] [Related]
20. ADMET considerations for restless leg syndrome drug treatments.
de Biase S; Merlino G; Lorenzut S; Valente M; Gigli GL
Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1247-61. PubMed ID: 22808933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
